Tempest Therapeutics, Inc.

US$0.38As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TPSTHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (67.03%)
Div yield —
ROE (931.14%)
Biotechnology
Beta (5Y) (1.56)
PE TTM —
TSR TTM (96.26%)
Mkt cap US$6.295M
ROIC (108.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.453
19.02%
124.74%
Hold 5|8|4|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
0.75%
(0.68%)
12.06%
9.29%
Revenue$M
0.816
0.856
0.850
0.841
6.44%
6.55%
6.88%
0.01%
Peers (US$6.295M)
Cap (US$)
PE
6.217M
—
6.306M
66.20x
Capital
TTM
5Y
10Y
Leveragex
0.244
0.164
0.170
EBIT/Intx
0.243
0.304
0.314
Own earn%
143.54
(4.38)
(4.53)
Sh yield%
32.52
16.83
20.22
Owners
Insiders/Inst%
10.12
25.75
Short interest%
2.50
SBC / revenue%
1.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
2–8
$1 testx
—
Incr. ROIC%
1